Sanford-Burnham Medical Research Institute, Daiichi Sankyo deal

Sanford-Burnham granted Daiichi a license to an undisclosed preclinical small molecule to treat cardiovascular-metabolic disease. The institute’s Conrad Prebys Center for Chemical Genomics discovered the undisclosed small molecule. The partners said financial terms of the deal and terms of the license are not disclosed. ...